All Stories

  1. Folic acid-targeted disulfide-based cross-linking micelle for enhanced drug encapsulation stability and site-specific drug delivery against tumors
  2. Integrin-targeted pH-responsive micelles for enhanced efficiency of anticancer treatment in vitro and in vivo
  3. Thermosensitive in situ hydrogel based on the hybrid of hyaluronic acid and modified PCL/PEG triblock copolymer
  4. Maintenance of Amyloid β Peptide Homeostasis by Artificial Chaperones Based on Mixed‐Shell Polymeric Micelles
  5. Synthesis, Biodistribution, and Imaging of PEGylated-Acetylated Polyamidoamine Dendrimers
  6. Self-Assembling Peptide of d-Amino Acids Boosts Selectivity and Antitumor Efficacy of 10-Hydroxycamptothecin
  7. Acid-induced disassemblable nanoparticles based on cyclic benzylidene acetal-functionalized graft copolymer via sequential RAFT and ATRP polymerization
  8. Real-time and non-invasive fluorescence tracking of in vivo degradation of the thermosensitive PEGlyated polyester hydrogel
  9. Improving the oral delivery efficiency of anticancer drugs by chitosan coated polycaprolactone-grafted hyaluronic acid nanoparticles
  10. Graft Copolymer Nanoparticles with pH and Reduction Dual-Induced Disassemblable Property for Enhanced Intracellular Curcumin Release
  11. Novel tumor-targeting, self-assembling peptide nanofiber as a carrier for effective curcumin delivery
  12. The impact of PEGylation patterns on the in vivo biodistribution of mixed shell micelles
  13. Comb-like Amphiphilic Copolymers Bearing Acetal-Functionalized Backbones with the Ability of Acid-Triggered Hydrophobic-to-Hydrophilic Transition as Effective Nanocarriers for Intracellular Release of Curcumin
  14. Tumor targeting and pH-responsive polyelectrolyte complex nanoparticles based on hyaluronic acid-paclitaxel conjugates and Chitosan for oral delivery of paclitaxel
  15. In Vivo Biodistribution of Mixed Shell Micelles with Tunable Hydrophilic/Hydrophobic Surface
  16. A novel mixed-component molecular hydrogel system with excellent stabilities
  17. Novel peptide–dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer